Results

Total Results: 1,650 records

Showing results for "factor".

1641. Prostate-Cancer-Test Executive (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/prostate-cancer-test_executive.pdf
      April 01, 2013 - prostate cancer based on elevated serum tPSA levels and/or suspicious digital rectal exam or other risk factor

1642. Obesity (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/10_obesity_potential_high_impact_june_2012.pdf
      January 01, 2012 - Obesity AHRQ Healthcare Horizon Scanning System – Potential High Impact Interventions Report Priority Area 10: Obesity Prepared for: Agency for Healthcare Research and Quality U.S. Department of Health and Human Services 540 Gaither Road Rockville, MD 20850 www.ahrq.gov Contract N…

1643. mHealth for Diabetes (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/tnd-0855-170515.pdf
      April 28, 2017 - mHealth for Diabetes i Results of Topic Selection Process & Next Steps The nominator, a managed care pharmacist, is interested in a new systematic review evaluating the effectiveness of mobile health (mHealth) technologies for diabetes. This topic met the Effective Health Care Program selection crit…

1644. mHealth for Diabetes (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND-0855-170515.pdf
      April 28, 2017 - mHealth for Diabetes i Results of Topic Selection Process & Next Steps The nominator, a managed care pharmacist, is interested in a new systematic review evaluating the effectiveness of mobile health (mHealth) technologies for diabetes. This topic met the Effective Health Care Program selection crit…

1645. autism-update-protocol-130920 (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/autism-update_research-protocol.pdf
      September 20, 2013 - autism-update-protocol-130920 Evidence-based Practice Center Systematic Review Protocol Project Title: Autism Spectrum Disorder—An Update I. Background and Objectives for the Systematic Review …

1646. Evidence-based Practice Center Systematic Review Protocol (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-anemia-update_research-protocol.pdf
      June 16, 2010 - increased expression of various cytokines, especially Interferon-g, Interleukin-1 and tumor necrosis factor … leukemia (CLL), cervical carcinoma and cancer of the head and neck, anemia is reportedly a prognostic factor

1647. Renal-Artery-Stenosis Surveillance (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/renal-artery-stenosis_surveillance.pdf
      June 01, 2012 - i CER-Update # 5: Comparative Effectiveness of Management Strategies for Renal Artery Stenosis: 2007 Update Original release date: 2007 Surveillance Report: August, 2012 Key Findings: • KQ1: 8 of 15 conclusions are probably out of date • KQ2: 1 of 3 conclusions is possibly out of …

1648. PEPTIC ULCER #11 (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/peptic-ulcer-horizon-scan-high-impact-1512.pdf
      December 01, 2015 - 83.0% to 90.6%) for patients with a circumferential area of Barrett’s esophagus of 3 cm or more, a factor … Cytosponge testing combined with immunohistochemical 3 staining for the biomarker trefoil factor … Evaluation of a minimally invasive cell sampling device coupled with assessment of trefoil factor

1649. C-Diff-Infections-Surveillance-140925 (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/c-diff-infections-surveillance-140925.pdf
      January 01, 2014 - The original report also included risk factor studies if the reviewers determined they were of good … One study found that a prior room occupant with CDI is a significant risk factor for CDI acquisition … The effect of room on CDI acquisition remained a significant risk factor (P=0.008) when Kaplan-Meier … The authors concluded that a prior room occupant with CDI is a significant risk factor for CDI acquisition … presumed that preservation of the normal intestinal flora during fidaxomicin treatment is a major factor

1650. Antiplatelet-Treatment Executive (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/antiplatelet-treatment_executive.pdf
      September 01, 2013 - Systematic review: anti-epidermal growth factor receptor treatment effect modification by KRAS mutations